-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On January 9, Zhongguancun announced that its subsidiary Beijing Huasu "Oxycodone Hydrochloride API and Injection" recently passed the technical review of the Drug Evaluation Center of the State Drug Administration, "Oxycodone Hydrochloride Injection".
Oxycodone Hydrochloride Injection is a potent analgesic indicated for the treatment of moderate to severe acute pain, including post-operative moderate to severe pain, and severe pain requiring treatment with strong opioids
Oxycodone hydrochloride injection was launched in China in 2013
Up to now, the domestic manufacturers that have obtained the "Drug Registration Certificate" of this product include Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co.